Cellulitis and erysipelas are two common skin infections that can cause red, swollen, and tender skin. Both are bacterial infections, but they have some important differences. This article takes a closer look at the differences between cellulitis and erysipelas, including their causes, symptoms, and treatments.
Cellulitis and erysipelas are both caused by bacterial infections. Cellulitis is usually caused by streptococcus or staphylococcus bacteria, while erysipelas is usually caused by the bacterium Streptococcus pyogenes. The bacteria that cause cellulitis and erysipelas can enter the body through a break in the skin, such as a cut, scrape, burn, or insect bite. They can also enter through a surgical wound or an area of skin that has been weakened by another infection, such as athlete’s foot or eczema.
The main symptom of both cellulitis and erysipelas is red, swollen, and tender skin. In both cases, the affected area may also be warm to the touch. Cellulitis can affect any area of the body, but it is most common on the face, arms, and legs. Erysipelas usually affects the face, especially the cheeks and the bridge of the nose. Other symptoms of cellulitis include fever, chills, fatigue, and swollen lymph nodes. Symptoms of erysipelas include fever, chills, and a bright red rash that may have a raised, scaly border.
Cellulitis and erysipelas can be difficult to distinguish from each other, so it is important to see a doctor for a proper diagnosis. To diagnose the infection, the doctor will examine the affected area and ask about your symptoms. They may also take a sample of the affected area and send it to a laboratory for testing.
The treatment for cellulitis and erysipelas is usually antibiotics, either taken orally or applied directly to the affected area. The type of antibiotic used will depend on the type of bacteria causing the infection. In some cases, the doctor may also recommend pain relievers, such as ibuprofen or acetaminophen, to help relieve pain and swelling. If the infection is severe, the doctor may also recommend hospitalization and intravenous antibiotics.
To help prevent cellulitis and erysipelas, it is important to keep the skin clean and dry, and to avoid cuts, scrapes, and insect bites. It is also important to treat any existing skin conditions, such as athlete’s foot or eczema, to reduce the risk of infection.
Cellulitis and erysipelas are two common bacterial skin infections that can cause red, swollen, and tender skin. Although they have some similarities, they also have some important differences. It is important to see a doctor for a proper diagnosis and treatment. To help prevent these infections, it is important to keep the skin clean and dry, and to treat any existing skin conditions.
1.
A new theranostic drug targets different cancer types.
2.
Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue
3.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Study offers clearer picture of childhood brain tumor survival
1.
Unlocking the Secrets of Leukemic Stem Cells: A Path to Better Blood Cancer Treatments
2.
Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology
3.
Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS
4.
Patient-Centric Approaches in Hematology: Integrating Individualized Care into Modern Clinical Practice
5.
The Dark Side of Melanoma: Uncovering the Risk Factors and Prevention Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation